Identification of fungal pathogens in Formalin-fixed, Paraffin-embedded tissue samples by molecular methods

Fungal Biology
Volker Rickerts

Abstract

The etiology of invasive fungal infections (IFI) is incompletely understood due to diagnostic limitations including insensitivity of cultures and failure of histopathology to discriminate between different species. This diagnostic gap precludes the optimal use of antifungals, leading to adverse patient outcomes. The identification of fungal pathogens from Formalin-fixed, Paraffin-embedded tissue (FFPE) blocks by molecular methods is emerging as an alternative approach to study the etiology of IFI. PCR assays, including species specific- and broadrange fungal tests are used with FFPE samples from patients with proven IFI. Fungal species identification is achieved in 15-90% of the samples. This heterogeneity may be explained by the samples studied. However, comparison of different studies is impaired, as controls ruling out false positive-, false negative test results or PCR inhibition are frequently not reported. Studies using in situ hybridization also vary in the clinical samples included and the targeted fungi. In addition, target sequences, the probe chemistry and the detection of hybridization signals also account for the differences in diagnostic sensitivity. Using both approaches in parallel yields additive insights, pote...Continue Reading

References

Feb 12, 1998·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·C S ParkK T Montone
Nov 5, 1999·Trends in Biochemical Sciences·J R Warner
May 29, 2000·Emerging Infectious Diseases·D N FredricksD A Relman
May 1, 2002·Journal of Clinical Microbiology·Ralf BialekRolf Hohle
Jun 5, 2002·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·R T HaydenR V Lloyd
Dec 4, 2002·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·V RickertsG Just-Nübling
Feb 8, 2003·Journal of Clinical Microbiology·Birgit WillingerManfred Rotter
Jun 24, 2003·American Journal of Clinical Pathology·Jeffrey J TarrandDimitrios P Kontoyiannis
Dec 14, 2004·Fungal Genetics and Biology : FG & B·Wieke R TeertstraHan A B Wösten
Oct 7, 2005·Journal of Clinical Microbiology·David N FredricksAmalia Meier
Dec 3, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P J PatersonC C Kibbler
Mar 17, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Volker RickertsRalf Bialek
Sep 25, 2007·Diagnostic Microbiology and Infectious Disease·Stephen A KlotzPeter N Lipke
Apr 17, 2008·Nature Reviews. Microbiology·Rudolf Amann, Bernhard M Fuchs
Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marcio Nucci, John R Perfect
Jan 1, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D NeofytosK Marr
Jan 14, 2009·Applied and Environmental Microbiology·Prasanna D KhotDavid N Fredricks
Dec 9, 2009·Expert Review of Anti-infective Therapy·Prasanna D Khot, David N Fredricks
Jan 23, 2010·Medical Mycology·Shinwon LeeMyoung-Don Oh
Jan 29, 2010·Journal of Clinical Microbiology·Jan W M van der LindenPaul E Verweij
Mar 12, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M L MartinsJ Inácio
Jul 20, 2010·Diagnostic Microbiology and Infectious Disease·Elizabeth HarrisonUNKNOWN Aspergillus Technology Consortium (AsTeC)
Jan 14, 2011·Journal of Clinical Microbiology·L MillonE Deconinck
Jan 14, 2011·American Journal of Clinical Pathology·Kathleen T MontoneIrving Nachamkin
Apr 22, 2011·Journal of Clinical Microbiology·Sarah P HammondFrancisco M Marty

❮ Previous
Next ❯

Citations

May 12, 2011·Revista iberoamericana de micología·Ivanete De Lima SampaioJoão Vicente Braga De Souza
Dec 17, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hideto TeranishiKazunobu Ouchi
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carlos A GomezNiaz Banaei
Jul 3, 2020·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Arnica KarunaWolfgang Langbein
Aug 24, 2019·Emerging Infectious Diseases·Isabelle RoomsVolker Rickerts
Jan 30, 2020·Frontiers in Microbiology·Sarah E KiddCatriona L Halliday
Jan 1, 2018·Current Fungal Infection Reports·Spinello AntinoriCarlo Parravicini
Apr 9, 2020·Frontiers in Microbiology·Afsane VaeziHamid Badali
Dec 1, 2020·Journal of Medical Microbiology·Joseph JillwinArunaloke Chakrabarti
Mar 4, 2021·Journal of Fungi·Breno Gonçalves PinheiroAnderson Messias Rodrigues
Mar 13, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shawn R LockhartDimitrios P Kontoyiannis
Jun 18, 2021·Respiratory Medicine·D WilmesN Kanaan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.